| Year |
Citation |
Score |
| 2020 |
Collado K, Kerns SL, Diefenbach MA, Peterson-Roth E, Koski R, Ostrer H, Stock RG, Mattessich M, Kaplan P, Rosenstein BS. Survey of Radiation Oncologists to Assess Interest and Potential Use of a Genetic Test Predicting Susceptibility for the Development of Toxicities After Prostate Cancer Radiation Therapy. Advances in Radiation Oncology. 5: 897-904. PMID 33083651 DOI: 10.1016/J.Adro.2020.03.019 |
0.317 |
|
| 2019 |
Kerns SL, Fachal L, Dorling L, Barnett GC, Baran A, Peterson DR, Hollenberg M, Hao K, Narzo AD, Ahsen ME, Pandey G, Bentzen SM, Janelsins M, Elliott RM, Pharoah PDP, ... ... Ostrer H, et al. Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy. Journal of the National Cancer Institute. PMID 31095341 DOI: 10.1093/Jnci/Djz075 |
0.384 |
|
| 2019 |
Pearlman A, Rahman MT, Upadhyay K, Loke J, Ostrer H. Ectopic Otoconin 90 expression in triple negative breast cancer cell lines is associated with metastasis functions. Plos One. 14: e0211737. PMID 30763339 DOI: 10.1371/Journal.Pone.0211737 |
0.574 |
|
| 2019 |
Schumacher FR, Olama AAA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, ... ... Ostrer H, et al. Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nature Genetics. PMID 30622367 DOI: 10.1038/S41588-018-0330-6 |
0.303 |
|
| 2018 |
Fofanov VY, Upadhyay K, Pearlman A, Loke J, O V, Shao Y, Freedland S, Ostrer H. Rapid Next-Generation Sequencing Method for Prediction of Prostate Cancer Risks. The Journal of Molecular Diagnostics : Jmd. PMID 30553750 DOI: 10.1016/J.Jmoldx.2018.07.007 |
0.601 |
|
| 2018 |
Dadaev T, Saunders EJ, Newcombe PJ, Anokian E, Leongamornlert DA, Brook MN, Cieza-Borrella C, Mijuskovic M, Wakerell S, Olama AAA, Schumacher FR, Berndt SI, Benlloch S, Ahmed M, Goh C, ... ... Ostrer H, et al. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. Nature Communications. 9: 2256. PMID 29892050 DOI: 10.1038/S41467-018-04109-8 |
0.383 |
|
| 2018 |
Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, ... ... Ostrer H, et al. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nature Genetics. PMID 29892016 DOI: 10.1038/S41588-018-0142-8 |
0.363 |
|
| 2018 |
Kerns S, Chuang KH, Hall W, Werner Z, Chen Y, Ostrer H, West C, Rosenstein B. Radiation biology and oncology in the genomic era. The British Journal of Radiology. 20170949. PMID 29888979 DOI: 10.1259/Bjr.20170949 |
0.368 |
|
| 2018 |
Pearlman A, Upadhyay K, Cole K, Loke J, Sun K, Fineberg S, Freedland SJ, Shao Y, Ostrer H. Robust genomic copy number predictor of pan cancer metastasis. Genes & Cancer. 9: 66-77. PMID 29725504 DOI: 10.18632/Genesandcancer.165 |
0.612 |
|
| 2018 |
Lencz T, Yu J, Palmer C, Carmi S, Ben-Avraham D, Barzilai N, Bressman S, Darvasi A, Cho JH, Clark LN, Gümüş ZH, Joseph V, Klein R, Lipkin S, Offit K, ... Ostrer H, et al. High-depth whole genome sequencing of an Ashkenazi Jewish reference panel: enhancing sensitivity, accuracy, and imputation. Human Genetics. PMID 29705978 DOI: 10.1007/S00439-018-1886-Z |
0.337 |
|
| 2018 |
Lee S, Kerns S, Ostrer H, Rosenstein B, Deasy JO, Oh JH. Machine Learning on a Genome-wide Association Study to Predict Late Genitourinary Toxicity After Prostate Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. PMID 29502932 DOI: 10.1016/J.Ijrobp.2018.01.054 |
0.349 |
|
| 2018 |
Kerns S, Fachal L, Dorling L, Barnett G, Burnet N, Sydes M, Dearnaley D, Dunning A, Pharoah P, Parliament M, Usmani N, de Ruyck K, Ostrer H, Rosenstein B, CaamaNo AG, et al. Meta-Analysis of Genome-Wide Association Studies (GWAS) of Late Toxicity in 3,874 Men Treated with Radiation for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 102: e738-e739. DOI: 10.1016/J.Ijrobp.2018.07.1976 |
0.358 |
|
| 2017 |
Granados A, Alaniz VI, Mohnach L, Barseghyan H, Vilain E, Ostrer H, Quint EH, Chen M, Keegan CE. MAP3K1-related gonadal dysgenesis: Six new cases and review of the literature. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics. PMID 28504475 DOI: 10.1002/Ajmg.C.31559 |
0.332 |
|
| 2017 |
Einhorn Y, Weissglas-Volkov D, Carmi S, Ostrer H, Friedman E, Shomron N. Differential analysis of mutations in the Jewish population and their implications for diseases. Genetics Research. 99: e3. PMID 28502252 DOI: 10.1017/S0016672317000015 |
0.402 |
|
| 2017 |
Syeda MM, Upadhyay K, Loke J, Pearlman A, Klugman S, Shao Y, Ostrer H. Prediction of breast cancer risk based on flow-variant analysis of circulating peripheral blood B cells. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 28301456 DOI: 10.1038/Gim.2016.222 |
0.571 |
|
| 2017 |
Oh JH, Kerns S, Ostrer H, Powell SN, Rosenstein B, Deasy JO. Computational methods using genome-wide association studies to predict radiotherapy complications and to identify correlative molecular processes. Scientific Reports. 7: 43381. PMID 28233873 DOI: 10.1038/Srep43381 |
0.344 |
|
| 2017 |
Kerns S, Hao K, Stahl E, Rosenstein B, CaamaNo AG, Carballo A, Peleteiro P, Fachal L, Vega A, Dunning A, Sydes M, Hall E, Dearnaley D, West C, Ostrer H. Contribution of Common SNPs to Variability in Late Radiation Therapy Toxicity in Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 99: E601. DOI: 10.1016/J.Ijrobp.2017.06.2047 |
0.321 |
|
| 2016 |
Oh J, Kerns S, Ostrer H, Rosenstein B, Deasy J. SU-D-204-06: Integration of Machine Learning and Bioinformatics Methods to Analyze Genome-Wide Association Study Data for Rectal Bleeding and Erectile Dysfunction Following Radiotherapy in Prostate Cancer. Medical Physics. 43: 3333. PMID 28046236 DOI: 10.1118/1.4955611 |
0.343 |
|
| 2016 |
Kerns SL, Dorling L, Fachal L, Bentzen S, Pharoah PD, Barnes DR, Gómez-Caamaño A, Carballo AM, Dearnaley DP, Peleteiro P, Gulliford SL, Hall E, Michailidou K, Carracedo Á, Sia M, ... ... Ostrer H, et al. Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer. Ebiomedicine. PMID 27515689 DOI: 10.1016/J.Ebiom.2016.07.022 |
0.401 |
|
| 2016 |
Andreassen CN, Rosenstein BS, Kerns SL, Ostrer H, De Ruysscher D, Cesaretti JA, Barnett GC, Dunning AM, Dorling L, West CM, Burnet NG, Elliott R, Coles C, Hall E, Fachal L, et al. Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 27443449 DOI: 10.1016/J.Radonc.2016.06.017 |
0.326 |
|
| 2016 |
Waldman YY, Biddanda A, Dubrovsky M, Campbell CL, Oddoux C, Friedman E, Atzmon G, Halperin E, Ostrer H, Keinan A. The genetic history of Cochin Jews from India. Human Genetics. PMID 27377974 DOI: 10.1007/S00439-016-1698-Y |
0.34 |
|
| 2016 |
Waldman YY, Biddanda A, Davidson NR, Billing-Ross P, Dubrovsky M, Campbell CL, Oddoux C, Friedman E, Atzmon G, Halperin E, Ostrer H, Keinan A. The Genetics of Bene Israel from India Reveals Both Substantial Jewish and Indian Ancestry. Plos One. 11: e0152056. PMID 27010569 DOI: 10.1371/Journal.Pone.0152056 |
0.329 |
|
| 2016 |
Oh J, Kerns S, Ostrer H, Rosenstein B, Deasy J. EP-2058: A novel multi-SNP model predictive of erectile dysfunction following radiotherapy in prostate cancer Radiotherapy and Oncology. 119: S971. DOI: 10.1016/S0167-8140(16)33309-6 |
0.327 |
|
| 2015 |
Kerns SL, Kundu S, Oh JH, Singhal SK, Janelsins M, Travis LB, Deasy JO, Janssens AC, Ostrer H, Parliament M, Usmani N, Rosenstein BS. The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention. Seminars in Radiation Oncology. 25: 281-91. PMID 26384276 DOI: 10.1016/J.Semradonc.2015.05.006 |
0.306 |
|
| 2015 |
Ostrer H. The origin of the p.E180 growth hormone receptor gene mutation. Growth Hormone & Igf Research : Official Journal of the Growth Hormone Research Society and the International Igf Research Society. PMID 26277320 DOI: 10.1016/J.Ghir.2015.08.003 |
0.368 |
|
| 2015 |
Loke J, Pearlman A, Upadhyay K, Tesfa L, Shao Y, Ostrer H. Functional variant analyses (FVAs) predict pathogenicity in the BRCA1 DNA double-strand break repair pathway. Human Molecular Genetics. 24: 3030-7. PMID 25652403 DOI: 10.1093/Hmg/Ddv048 |
0.584 |
|
| 2014 |
Ow TJ, Upadhyay K, Belbin TJ, Prystowsky MB, Ostrer H, Smith RV. Bioinformatics in otolaryngology research. Part two: Other high-throughput platforms in genomics and epigenetics Journal of Laryngology and Otology. 128: 942-947. PMID 25230349 DOI: 10.1017/S0022215114002011 |
0.303 |
|
| 2014 |
Carmi S, Hui KY, Kochav E, Liu X, Xue J, Grady F, Guha S, Upadhyay K, Ben-Avraham D, Mukherjee S, Bowen BM, Thomas T, Vijai J, Cruts M, Froyen G, ... ... Ostrer H, et al. Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins. Nature Communications. 5: 4835. PMID 25203624 DOI: 10.1038/Ncomms5835 |
0.356 |
|
| 2014 |
Vacic V, Ozelius LJ, Clark LN, Bar-Shira A, Gana-Weisz M, Gurevich T, Gusev A, Kedmi M, Kenny EE, Liu X, Mejia-Santana H, Mirelman A, Raymond D, Saunders-Pullman R, Desnick RJ, ... ... Ostrer H, et al. Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes. Human Molecular Genetics. 23: 4693-702. PMID 24842889 DOI: 10.1093/Hmg/Ddu158 |
0.315 |
|
| 2014 |
Hiraki S, Rinella ES, Schnabel F, Oratz R, Ostrer H. Cancer risk assessment using genetic panel testing: considerations for clinical application. Journal of Genetic Counseling. 23: 604-17. PMID 24599651 DOI: 10.1007/S10897-014-9695-6 |
0.358 |
|
| 2014 |
Kerns SL, Ostrer H, Rosenstein BS. Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy. Cancer Discovery. 4: 155-65. PMID 24441285 DOI: 10.1158/2159-8290.Cd-13-0197 |
0.334 |
|
| 2014 |
Loke J, Pearlman A, Radi O, Zuffardi O, Giussani U, Pallotta R, Camerino G, Ostrer H. Mutations in MAP3K1 tilt the balance from SOX9/FGF9 to WNT/β-catenin signaling. Human Molecular Genetics. 23: 1073-83. PMID 24135036 DOI: 10.1093/Hmg/Ddt502 |
0.554 |
|
| 2014 |
Kerns S, Barnett G, Dorling L, Fachal L, Burnet N, Ostrer H, Parliament M, Rosenstein B, Vega A, West C. OC-0142: Radiogenomics consortium meta-analysis of genome wide association studies of prostate radiotherapy late toxicity Radiotherapy and Oncology. 111: S55. DOI: 10.1016/S0167-8140(15)30247-4 |
0.334 |
|
| 2013 |
Isakov O, Rinella ES, Olchovsky D, Shimon I, Ostrer H, Shomron N, Friedman E. Missense mutation in the MEN1 gene discovered through whole exome sequencing co-segregates with familial hyperparathyroidism. Genetics Research. 95: 114-20. PMID 24074368 DOI: 10.1017/S0016672313000141 |
0.35 |
|
| 2013 |
Botigué LR, Henn BM, Gravel S, Maples BK, Gignoux CR, Corona E, Atzmon G, Burns E, Ostrer H, Flores C, Bertranpetit J, Comas D, Bustamante CD. Gene flow from North Africa contributes to differential human genetic diversity in southern Europe. Proceedings of the National Academy of Sciences of the United States of America. 110: 11791-6. PMID 23733930 DOI: 10.1073/Pnas.1306223110 |
0.345 |
|
| 2013 |
Kerns SL, Stock RG, Stone NN, Blacksburg SR, Rath L, Vega A, Fachal L, Gómez-Caamaño A, De Ruysscher D, Lammering G, Parliament M, Blackshaw M, Sia M, Cesaretti J, Terk M, ... ... Ostrer H, et al. Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 107: 372-6. PMID 23719583 DOI: 10.1016/J.Radonc.2013.05.001 |
0.375 |
|
| 2013 |
Zeegers MP, Nekeman D, Khan HS, van Dijk BA, Goldbohm RA, Schalken J, Shajahan S, Pearlman A, Oddoux C, van den Brandt PA, Schouten LJ, Ostrer H. Prostate cancer susceptibility genes on 8p21-23 in a Dutch population. Prostate Cancer and Prostatic Diseases. 16: 248-53. PMID 23628848 DOI: 10.1038/Pcan.2013.9 |
0.615 |
|
| 2013 |
Kerns SL, Stone NN, Stock RG, Rath L, Ostrer H, Rosenstein BS. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer. The Journal of Urology. 190: 102-8. PMID 23376709 DOI: 10.1016/J.Juro.2013.01.096 |
0.356 |
|
| 2013 |
Rinella ES, Shao Y, Yackowski L, Pramanik S, Oratz R, Schnabel F, Guha S, LeDuc C, Campbell CL, Klugman SD, Terry MB, Senie RT, Andrulis IL, Daly M, John EM, ... ... Ostrer H, et al. Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation. Human Genetics. 132: 523-36. PMID 23354978 DOI: 10.1007/S00439-013-1269-4 |
0.359 |
|
| 2013 |
Sarsour K, Greenberg J, Johnston JA, Nelson DR, O'Brien LA, Oddoux C, Ostrer H, Pearlman A, Reed G. The role of the FcGRIIIa polymorphism in modifying the association between treatment and outcome in patients with rheumatoid arthritis treated with rituximab versus TNF-α antagonist therapies. Clinical and Experimental Rheumatology. 31: 189-94. PMID 23294992 |
0.479 |
|
| 2013 |
Ostrer H, Skorecki K. The population genetics of the Jewish people. Human Genetics. 132: 119-27. PMID 23052947 DOI: 10.1007/S00439-012-1235-6 |
0.351 |
|
| 2013 |
Kerns SL, Stock R, Stone N, Buckstein M, Shao Y, Campbell C, Rath L, De Ruysscher D, Lammering G, Hixson R, Cesaretti J, Terk M, Ostrer H, Rosenstein BS. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 85: e21-8. PMID 23021708 DOI: 10.1016/J.Ijrobp.2012.08.003 |
0.362 |
|
| 2012 |
Pearlman A, Campbell C, Brooks E, Genshaft A, Shajahan S, Ittman M, Bova GS, Melamed J, Holcomb I, Schneider RJ, Ostrer H. Clustering-Based Method for Developing a Genomic Copy Number Alteration Signature for Predicting the Metastatic Potential of Prostate Cancer. Journal of Probability and Statistics. 2012: 873570. PMID 25419216 DOI: 10.1155/2012/873570 |
0.602 |
|
| 2012 |
Brisbin A, Bryc K, Byrnes J, Zakharia F, Omberg L, Degenhardt J, Reynolds A, Ostrer H, Mezey JG, Bustamante CD. PCAdmix: principal components-based assignment of ancestry along each chromosome in individuals with admixed ancestry from two or more populations. Human Biology. 84: 343-64. PMID 23249312 DOI: 10.3378/027.084.0401 |
0.338 |
|
| 2012 |
Campbell CL, Palamara PF, Dubrovsky M, Botigué LR, Fellous M, Atzmon G, Oddoux C, Pearlman A, Hao L, Henn BM, Burns E, Bustamante CD, Comas D, Friedman E, Pe'er I, ... Ostrer H, et al. North African Jewish and non-Jewish populations form distinctive, orthogonal clusters. Proceedings of the National Academy of Sciences of the United States of America. 109: 13865-70. PMID 22869716 DOI: 10.1073/Pnas.1204840109 |
0.548 |
|
| 2012 |
Kenny EE, Pe'er I, Karban A, Ozelius L, Mitchell AA, Ng SM, Erazo M, Ostrer H, Abraham C, Abreu MT, Atzmon G, Barzilai N, Brant SR, Bressman S, Burns ER, et al. A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. Plos Genetics. 8: e1002559. PMID 22412388 DOI: 10.1371/Journal.Pgen.1002559 |
0.35 |
|
| 2012 |
Loke J, Ostrer H. Rapidly screening variants of uncertain significance in the MAP3K1 gene for phenotypic effects. Clinical Genetics. 81: 272-7. PMID 22171599 DOI: 10.1111/J.1399-0004.2011.01834.X |
0.345 |
|
| 2012 |
Velez C, Palamara PF, Guevara-Aguirre J, Hao L, Karafet T, Guevara-Aguirre M, Pearlman A, Oddoux C, Hammer M, Burns E, Pe'Er I, Atzmon G, Ostrer H. The impact of Converso Jews on the genomes of modern Latin Americans Human Genetics. 131: 251-263. PMID 21789512 DOI: 10.1007/S00439-011-1072-Z |
0.592 |
|
| 2012 |
Parliament M, Broadhurst D, Ghosh S, Zhu G, Kerns S, Rosenstein B, Khitrov G, Ostrer H, Warkentin B, Murray D. Single-Nucleotide Polymorphisms (SNPs) Associated With Radiation Proctitis From Genome-wide False Discovery Rate Analysis International Journal of Radiation Oncology*Biology*Physics. 84: S712-S713. DOI: 10.1016/J.Ijrobp.2012.07.1907 |
0.307 |
|
| 2012 |
Ko E, Kerns S, Stone N, Stock R, Ostrer H, Rosenstein B. Association of Genetic Factors With PSA Response in Prostate Cancer Patients Receiving Definitive Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 84: S403-S404. DOI: 10.1016/J.Ijrobp.2012.07.1066 |
0.337 |
|
| 2012 |
Kerns S, Stock R, Stone N, Rath L, Ostrer H, Rosenstein B. Genome Wide Association Study to Identify Genetic Variants Associated With Urinary Symptoms Following Radiation Therapy for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S401-S402. DOI: 10.1016/J.Ijrobp.2012.07.1060 |
0.367 |
|
| 2011 |
Lobach I, Belitskaya-Levy I, Goldberg JD, Ostrer H, Berman RS, Pavlick AC, Shapiro RL, Osman I, Manga P. Impact of population genetic substructure on association studies and risk assessment for melanoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 8521. PMID 28021107 DOI: 10.1200/Jco.2011.29.15_Suppl.8521 |
0.353 |
|
| 2011 |
Warr N, Bogani D, Siggers P, Brixey R, Tateossian H, Dopplapudi A, Wells S, Cheeseman M, Xia Y, Ostrer H, Greenfield A. Minor abnormalities of testis development in mice lacking the gene encoding the MAPK signalling component, MAP3K1. Plos One. 6: e19572. PMID 21559298 DOI: 10.1371/Journal.Pone.0019572 |
0.331 |
|
| 2011 |
Moorjani P, Patterson N, Hirschhorn JN, Keinan A, Hao L, Atzmon G, Burns E, Ostrer H, Price AL, Reich D. The history of African gene flow into Southern Europeans, Levantines, and Jews. Plos Genetics. 7: e1001373. PMID 21533020 DOI: 10.1371/Journal.Pgen.1001373 |
0.325 |
|
| 2011 |
Kaklamani V, Yi N, Zhang K, Sadim M, Offit K, Oddoux C, Ostrer H, Mantzoros C, Pasche B. Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk. Metabolism: Clinical and Experimental. 60: 1234-43. PMID 21397927 DOI: 10.1016/J.Metabol.2011.01.005 |
0.318 |
|
| 2011 |
Rose AE, Poliseno L, Wang J, Clark M, Pearlman A, Wang G, Vega Y Saenz de Miera EC, Medicherla R, Christos PJ, Shapiro R, Pavlick A, Darvishian F, Zavadil J, Polsky D, Hernando E, ... Ostrer H, et al. Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression. Cancer Research. 71: 2561-71. PMID 21343389 DOI: 10.1158/0008-5472.Can-10-2958 |
0.581 |
|
| 2011 |
Zeegers MP, Khan HS, Schouten LJ, van Dijk BA, Goldbohm RA, Schalken J, Shajahan S, Pearlman A, Oddoux C, van den Brandt PA, Ostrer H. Genetic marker polymorphisms on chromosome 8q24 and prostate cancer in the Dutch population: DG8S737 may not be the causative variant. European Journal of Human Genetics : Ejhg. 19: 118-20. PMID 20700145 DOI: 10.1038/Ejhg.2010.133 |
0.621 |
|
| 2011 |
Kerns S, Stone N, Stock R, Shao Y, Ostrer H, Rosenstein B. 344 GENETIC FACTORS INFLUENCE TIME TO UNDETECTABLE PSA IN MEN WITH PROSTATE CANCER TREATED BY RADIOTHERAPY Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.428 |
0.331 |
|
| 2010 |
Pearlman A, Loke J, Le Caignec C, White S, Chin L, Friedman A, Warr N, Willan J, Brauer D, Farmer C, Brooks E, Oddoux C, Riley B, Shajahan S, Camerino G, ... ... Ostrer H, et al. Mutations in MAP3K1 cause 46,XY disorders of sex development and implicate a common signal transduction pathway in human testis determination. American Journal of Human Genetics. 87: 898-904. PMID 21129722 DOI: 10.1016/J.Ajhg.2010.11.003 |
0.582 |
|
| 2010 |
Kerns SL, Ostrer H, Stock R, Li W, Moore J, Pearlman A, Campbell C, Shao Y, Stone N, Kusnetz L, Rosenstein BS. Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 78: 1292-300. PMID 20932654 DOI: 10.1016/J.Ijrobp.2010.07.036 |
0.597 |
|
| 2010 |
Atzmon G, Hao L, Pe'er I, Velez C, Pearlman A, Palamara PF, Morrow B, Friedman E, Oddoux C, Burns E, Ostrer H. Abraham's children in the genome era: major Jewish diaspora populations comprise distinct genetic clusters with shared Middle Eastern Ancestry. American Journal of Human Genetics. 86: 850-9. PMID 20560205 DOI: 10.1016/J.Ajhg.2010.04.015 |
0.578 |
|
| 2010 |
Bryc K, Velez C, Karafet T, Moreno-Estrada A, Reynolds A, Auton A, Hammer M, Bustamante CD, Ostrer H. Colloquium paper: genome-wide patterns of population structure and admixture among Hispanic/Latino populations. Proceedings of the National Academy of Sciences of the United States of America. 107: 8954-61. PMID 20445096 DOI: 10.1073/Pnas.0914618107 |
0.343 |
|
| 2010 |
Ligr M, Li Y, Zou X, Daniels G, Melamed J, Peng Y, Wang W, Wang J, Ostrer H, Pagano M, Wang Z, Garabedian MJ, Lee P. Tumor suppressor function of androgen receptor coactivator ARA70alpha in prostate cancer. The American Journal of Pathology. 176: 1891-900. PMID 20167864 DOI: 10.2353/Ajpath.2010.090293 |
0.303 |
|
| 2010 |
Refai O, Friedman A, Terry L, Jewett T, Pearlman A, Perle MA, Ostrer H. De novo 12;17 translocation upstream of SOX9 resulting in 46,XX testicular disorder of sex development. American Journal of Medical Genetics. Part A. 152: 422-6. PMID 20082466 DOI: 10.1002/Ajmg.A.33201 |
0.569 |
|
| 2010 |
Rose AE, Poliseno L, Pearlman A, Wang J, Ostrer H, Darvishian F, Shapiro RL, Pavlick AC, Hernando E, Osman I. The use of integrative genomics to define molecular signatures of melanoma histologic subtypes. Journal of Clinical Oncology. 28: 8553-8553. DOI: 10.1200/Jco.2010.28.15_Suppl.8553 |
0.549 |
|
| 2009 |
Sidash S, Ostrer H, Goldberg JD, Belitskaya-Levy I, Lobach IV, Polsky D, Shapiro RL, Berman RS, Osman I, Manga P. Evaluation of the melanocortin-1-receptor gene in melanoma predisposition, progression, and recurrence. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 9018. PMID 27962381 DOI: 10.1200/Jco.2009.27.15_Suppl.9018 |
0.341 |
|
| 2009 |
Rose AE, Wang J, Pearlman A, Doudican N, Hernando E, Orlow SJ, Polsky D, Ostrer H, Osman I. The unique molecular signatures of nodular and superficial spreading melanoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 9047. PMID 27962135 DOI: 10.1200/Jco.2009.27.15_Suppl.9047 |
0.529 |
|
| 2009 |
Manga P, Goldberg JD, Belitskaya-Levy I, Lobach I, Polsky D, Pavlick A, Shapiro R, Berman R, Osman I, Ostrer H. Developing genetic markers for melanoma risk assessment. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 9046. PMID 27962112 DOI: 10.1200/Jco.2009.27.15_Suppl.9046 |
0.33 |
|
| 2009 |
Valenzuela CD, Moore HG, Huang WC, Reich EW, Yee H, Ostrer H, Pachter HL. Three synchronous primary carcinomas in a patient with HNPCC associated with a novel germline mutation in MLH1: Case report. World Journal of Surgical Oncology. 7: 94. PMID 19995443 DOI: 10.1186/1477-7819-7-94 |
0.346 |
|
| 2009 |
Bogani D, Siggers P, Brixey R, Warr N, Beddow S, Edwards J, Williams D, Wilhelm D, Koopman P, Flavell RA, Chi H, Ostrer H, Wells S, Cheeseman M, Greenfield A. Loss of mitogen-activated protein kinase kinase kinase 4 (MAP3K4) reveals a requirement for MAPK signalling in mouse sex determination. Plos Biology. 7: e1000196. PMID 19753101 DOI: 10.1371/Journal.Pbio.1000196 |
0.305 |
|
| 2009 |
Purushothaman R, Gunturu SD, Anhalt H, Ten S, Friedman A, Pearlman A, Ostrer H. Array comparative genomic hybridization analysis of heritable Xp deletion. American Journal of Medical Genetics. Part A. 149: 529-31. PMID 19213022 DOI: 10.1002/Ajmg.A.32658 |
0.563 |
|
| 2009 |
Hatcher DM, Daniels G, Lin L, Basturk O, Zou X, Ostrer H, Wei J, Lepor H, Osman I, Lee P. EPITHELIAL AND STROMAL MICRORNA EXPRESSION IN RACIAL DISPARITY OF PROSTATE CANCER Journal of Urology. 181: 773-774. DOI: 10.1016/S0022-5347(09)62154-6 |
0.309 |
|
| 2008 |
Burri RJ, Stock RG, Cesaretti JA, Atencio DP, Peters S, Peters CA, Fan G, Stone NN, Ostrer H, Rosenstein BS. Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer. Radiation Research. 170: 49-59. PMID 18582155 DOI: 10.1667/Rr1219.1 |
0.33 |
|
| 2008 |
Fischer I, Cunliffe C, Bollo RJ, Weiner HL, Devinsky O, Ruiz-Tachiquin ME, Venuto T, Pearlman A, Chiriboga L, Schneider RJ, Ostrer H, Miller DC. Glioma-like proliferation within tissues excised as tubers in patients with tuberous sclerosis complex. Acta Neuropathologica. 116: 67-77. PMID 18581125 DOI: 10.1007/S00401-008-0391-1 |
0.553 |
|
| 2008 |
Kaklamani VG, Sadim M, Hsi A, Offit K, Oddoux C, Ostrer H, Ahsan H, Pasche B, Mantzoros C. Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. Cancer Research. 68: 3178-84. PMID 18451143 DOI: 10.1158/0008-5472.Can-08-0533 |
0.318 |
|
| 2008 |
Peters CA, Stock RG, Cesaretti JA, Atencio DP, Peters S, Burri RJ, Stone NN, Ostrer H, Rosenstein BS. TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy. International Journal of Radiation Oncology, Biology, Physics. 70: 752-9. PMID 17689884 DOI: 10.1016/J.Ijrobp.2007.05.023 |
0.326 |
|
| 2007 |
Grau JB, Pirelli L, Yu PJ, Galloway AC, Ostrer H. The genetics of mitral valve prolapse Clinical Genetics. 72: 288-295. PMID 17850623 DOI: 10.1111/J.1399-0004.2007.00865.X |
0.301 |
|
| 2006 |
Kaklamani VG, Baddi L, Liu J, Rosman D, Phukan S, Bradley C, Hegarty C, McDaniel B, Rademaker A, Oddoux C, Ostrer H, Michel LS, Huang H, Chen Y, Ahsan H, et al. Erratum: Combined genetic assessment of transforming growth factor-β signaling pathway variants may predict breast cancer risk (Cancer Research (April 15, 2005) 65 (3454-3461)) Cancer Research. 66. DOI: 10.1158/0008-5472.Can-66-6-Cor |
0.313 |
|
| 2005 |
Zeegers MP, Ostrer H. Genes in the polyamine biosynthesis pathway may be involved in prostate cancer susceptibility. Future Oncology (London, England). 1: 683-8. PMID 16556045 DOI: 10.2217/14796694.1.5.683 |
0.354 |
|
| 2004 |
Daruwala RS, Rudra A, Ostrer H, Lucito R, Wigler M, Mishra B. A versatile statistical analysis algorithm to detect genome copy number variation. Proceedings of the National Academy of Sciences of the United States of America. 101: 16292-7. PMID 15534219 DOI: 10.1073/Pnas.0407247101 |
0.334 |
|
| 2004 |
Kaklamani V, Baddi L, Rosman D, Liu J, Ellis N, Oddoux C, Ostrer H, Chen Y, Ahsan H, Offit K, Pasche B. No major association between TGFBR1*6A and prostate cancer. Bmc Genetics. 5: 28. PMID 15385056 DOI: 10.1186/1471-2156-5-28 |
0.344 |
|
| 2004 |
Olson SH, Carlson MDA, Ostrer H, Harlap S, Stone A, Winters M, Ambrosone CB. Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer Gynecologic Oncology. 93: 615-620. PMID 15196853 DOI: 10.1016/J.Ygyno.2004.03.027 |
0.325 |
|
| 2004 |
Fitzgerald T, Duva S, Ostrer H, Pass K, Oddoux C, Ruben R, Caggana M. The frequency of GJB2 and GJB6 mutations in the New York State newborn population: Feasibility of genetic screening for hearing defects Clinical Genetics. 65: 338-342. PMID 15025729 DOI: 10.1111/J.1399-0004.2004.00233.X |
0.338 |
|
| 2004 |
Zeegers MP, van Poppel F, Vlietinck R, Spruijt L, Ostrer H. Founder mutations among the Dutch. European Journal of Human Genetics : Ejhg. 12: 591-600. PMID 15010701 DOI: 10.1007/978-90-368-0705-0_2 |
0.348 |
|
| 2004 |
Ostrer H. Alterations of sex differentiation in males: from candidate genes to diagnosis and treatments. Current Pharmaceutical Design. 10: 501-11. PMID 14965335 DOI: 10.2174/1381612043453207 |
0.309 |
|
| 2004 |
Behar DM, Garrigan D, Kaplan ME, Mobasher Z, Rosengarten D, Karafet TM, Quintana-Murci L, Ostrer H, Skorecki K, Hammer MF. Contrasting patterns of Y chromosome variation in Ashkenazi Jewish and host non-Jewish European populations. Human Genetics. 114: 354-65. PMID 14740294 DOI: 10.1007/S00439-003-1073-7 |
0.339 |
|
| 2003 |
Jawaheer D, Juo SHH, Le Caignec C, David A, Petit C, Gregersen P, Dowbak S, Damle A, McElreavey K, Ostrer H. Mapping a gene for 46,XY gonadal dysgenesis by linkage analysis Clinical Genetics. 63: 530-535. PMID 12786760 DOI: 10.1034/J.1399-0004.2003.00082.X |
0.336 |
|
| 2003 |
Nieder AM, Taneja SS, Zeegers MP, Ostrer H. Genetic counseling for prostate cancer risk. Clinical Genetics. 63: 169-76. PMID 12694223 DOI: 10.1034/J.1399-0004.2003.00038.X |
0.367 |
|
| 2002 |
Kurima K, Peters LM, Yang Y, Riazuddin S, Ahmed ZM, Naz S, Arnaud D, Drury S, Mo J, Makishima T, Ghosh M, Menon PS, Deshmukh D, Oddoux C, Ostrer H, et al. Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair-cell function. Nature Genetics. 30: 277-84. PMID 11850618 DOI: 10.1038/Ng842 |
0.34 |
|
| 2001 |
Ostrer H. Identifying genes for male sex determination in humans Journal of Experimental Zoology. 290: 567-573. PMID 11748605 DOI: 10.1002/Jez.1107 |
0.355 |
|
| 2001 |
Ostrer H. A genetic profile of contemporary Jewish populations Nature Reviews Genetics. 2: 891-898. PMID 11715044 DOI: 10.1038/35098506 |
0.318 |
|
| 2001 |
Ostrer H. Genome and hormones: Gender differences in physiology invited review: Sex-based differences in gene expression Journal of Applied Physiology. 91: 2384-2388. PMID 11641384 DOI: 10.1152/Jappl.2001.91.5.2384 |
0.345 |
|
| 2001 |
Ostrer H. Sex determination: Lessons from families and embryos Clinical Genetics. 59: 207-215. PMID 11298673 DOI: 10.1034/J.1399-0004.2001.590401.X |
0.329 |
|
| 2000 |
Hammer MF, Redd AJ, Wood ET, Bonner MR, Jarjanazi H, Karafet T, Santachiara-Benerecetti S, Oppenheim A, Jobling MA, Jenkins T, Ostrer H, Bonne-Tamir B. Jewish and Middle Eastern non-Jewish populations share a common pool of Y-chromosome biallelic haplotypes. Proceedings of the National Academy of Sciences of the United States of America. 97: 6769-74. PMID 10801975 DOI: 10.1073/Pnas.100115997 |
0.311 |
|
| 2000 |
Sarafoglou K, Ostrer H. Clinical review 111: Familial sex reversal - A review Journal of Clinical Endocrinology and Metabolism. 85: 483-493. PMID 10690846 DOI: 10.1210/Jcem.85.2.6418 |
0.343 |
|
| 1999 |
Oddoux C, Guillen-Navarro E, Ditivoli C, Dicave E, Cilio MR, Clayton CM, Nelson H, Sarafoglou K, McCain N, Peretz H, Seligsohn U, Luzzatto L, Nafa K, Nardi M, Karpatkin M, ... ... Ostrer H, et al. Mendelian diseases among Roman Jews: Implications for the origins of disease alleles Journal of Clinical Endocrinology and Metabolism. 84: 4405-4409. PMID 10599695 DOI: 10.1210/Jcem.84.12.6268 |
0.307 |
|
| 1999 |
Ostrer H. Sex-based differences in gene transmission and gene expression Lupus. 8: 365-369. PMID 10455514 DOI: 10.1177/096120339900800507 |
0.33 |
|
| 1999 |
Aksentijevich I, Torosyan Y, Samuels J, Centola M, Pras E, Chae JJ, Oddoux C, Wood G, Azzaro MP, Palumbo G, Giustolisi R, Pras M, Ostrer H, Kastner DL. Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population American Journal of Human Genetics. 64: 949-962. PMID 10090880 DOI: 10.1086/302327 |
0.322 |
|
| 1997 |
Laken SJ, Petersen GM, Gruber SB, Oddoux C, Ostrer H, Giardiello FM, Hamilton SR, Hampel H, Markowitz A, Klimstra D, Jhanwar S, Winawer S, Offit K, Luce MC, Kinzler KW, et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC Nature Genetics. 17: 79-83. PMID 9288102 DOI: 10.1038/Ng0997-79 |
0.329 |
|
| 1997 |
Veitia R, Ion A, Barbaux S, Jobling MA, Souleyreau N, Ennis K, Ostrer H, Tosi M, Meo T, Chibani J, Fellous M, McElreavey K. Mutations and sequence variants in the testis-determining region of the Y chromosome in individuals with a 46,XY female phenotype. Human Genetics. 99: 648-52. PMID 9150734 DOI: 10.1007/S004390050422 |
0.345 |
|
| 1996 |
Fuqua JS, Sher ES, Fechner PY, Ostrer H, Oddeux C, Schafer AJ, Rosales TO, Migeon CJ, Berkovitz GD. Linkage analysis of a kindred with inherited 46,XY partial gonadal dysgenesis. The Journal of Clinical Endocrinology and Metabolism. 81: 4479-83. PMID 8954063 DOI: 10.1210/Jc.81.12.4479 |
0.346 |
|
| 1996 |
Oddoux C, Struewing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, Haas B, Norton L, Borgen P, Jhanwar S, Goldgar D, Ostrer H, Offit K. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1% Nature Genetics. 14: 188-190. PMID 8841192 DOI: 10.1038/Ng1096-188 |
0.322 |
|
| 1995 |
Oddoux C, Reich E, Axelrod F, Blumenfeld A, Maayan C, Slaugenhaupt S, Gusella J, Ostrer H. Prenatal diagnostic testing for familial dysautonomia using linked genetic markers Prenatal Diagnosis. 15: 817-826. PMID 8559751 DOI: 10.1002/Pd.1970150905 |
0.316 |
|
| Show low-probability matches. |